REGENERON PHARMACEUTICALS, INC. Insider Trading for January 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for January 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | A | 413.33 | 10,838 | 4,479,671 | 10,838 | |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Gift | G | 0.00 | 2,355 | 0 | 47,500 | 49.9 K to 47.5 K (-4.72 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 413.33 | 10,838 | 4,479,671 | 10,838 | |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Option Exercise | M | 52.03 | 25,000 | 1,300,750 | 37,079 | |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 418.40 | 300 | 125,520 | 10,711 | 11 K to 10.7 K (-2.72 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 417.44 | 1,000 | 417,440 | 11,011 | 12 K to 11 K (-8.33 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 416.75 | 900 | 375,075 | 12,011 | 12.9 K to 12 K (-6.97 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 415.20 | 1,642 | 681,758 | 12,911 | 14.6 K to 12.9 K (-11.28 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 414.07 | 2,758 | 1,142,005 | 14,553 | 17.3 K to 14.6 K (-15.93 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 412.81 | 1,700 | 701,777 | 17,311 | 19 K to 17.3 K (-8.94 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 411.99 | 1,122 | 462,253 | 19,011 | 20.1 K to 19 K (-5.57 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Sell | S | 410.99 | 1,400 | 575,386 | 20,133 | 21.5 K to 20.1 K (-6.50 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Payment of Exercise | F | 412.78 | 11,027 | 4,551,725 | 21,533 | 32.6 K to 21.5 K (-33.87 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Payment of Exercise | F | 412.78 | 3,151 | 1,300,670 | 32,560 | 35.7 K to 32.6 K (-8.82 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Buy | M | 52.03 | 25,000 | 1,300,750 | 35,711 | 10.7 K to 35.7 K (+233.40 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | A | 413.33 | 10,838 | 4,479,671 | 10,838 | |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Option Exercise | A | 413.33 | 10,838 | 4,479,671 | 10,838 | |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | A | 413.33 | 10,838 | 4,479,671 | 10,838 | |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Option Exercise | A | 413.33 | 10,838 | 4,479,671 | 10,838 | |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | A | 413.33 | 10,838 | 4,479,671 | 10,838 | |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | A | 413.33 | 10,838 | 4,479,671 | 10,838 | |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Gift | G | 0.00 | 2,000 | 0 | 18,349 | 20.3 K to 18.3 K (-9.83 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | INGRAM ROBERT ALEXANDER | Director | Option Exercise | A | 413.33 | 10,838 | 4,479,671 | 10,838 | |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | C | 0.00 | 1,500 | 0 | 15,775 | |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 416.00 | 100 | 41,600 | 0 | 100 to 0 (-100.00 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 413.88 | 100 | 41,388 | 100 | 200 to 100 (-50.00 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 412.23 | 200 | 82,446 | 200 | 400 to 200 (-50.00 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 410.47 | 403 | 165,419 | 400 | 803 to 400 (-50.19 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 409.28 | 300 | 122,784 | 803 | 1.1 K to 803 (-27.20 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Sell | S | 408.64 | 397 | 162,230 | 1,103 | 1.5 K to 1.1 K (-26.47 %) |
| Jan 05 2015 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | C | 0.00 | 1,500 | 0 | 1,500 | 0 to 1.5 K |